Zoetis (ZTS) EBT Growth (1y) (2013 - 2026)
Zoetis (ZTS) EBT Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -324.14% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -1.93% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | -8.74% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 70.52% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 1.69% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 124.00% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.09 Bn | 7.43 Bn | 397.90 Mn | -101.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.04% |
| Mar 31, 2026 | -1.94% |
| Dec 31, 2025 | 3.96% |
| Sep 30, 2025 | 1.49% |
| Jun 30, 2025 | 15.64% |
| Mar 31, 2025 | 3.48% |
| Dec 31, 2024 | 12.62% |
| Sep 30, 2024 | 21.90% |
| Jun 30, 2024 | -10.55% |
| Mar 31, 2024 | 7.17% |
| Dec 31, 2023 | 9.80% |
| Sep 30, 2023 | 7.50% |
| Jun 30, 2023 | 30.15% |
| Mar 31, 2023 | -4.13% |
| Dec 31, 2022 | 17.00% |
| Sep 30, 2022 | 1.21% |
| Jun 30, 2022 | 5.35% |
| Mar 31, 2022 | 5.82% |
| Dec 31, 2021 | 20.48% |
| Sep 30, 2021 | 10.39% |